AUTONOMY: The First Randomized Trial Comparing Two Patient-Driven Approaches to Initiate and Titrate Prandial Insulin Lispro in Type 2 Diabetes

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Diabetes Care

• Publication date

  2014-07-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/dc13-2664PMID 24742662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Inertia in People With Type 2 Diabetes: A Retrospective Cohort Study of More Than 80,000 People. Diabetes Care 2013;36:3411-3417

  2014cited by this paper
• Management of Type 2 Diabetes - Methods for Addition of Prandial to Basal Insulin.

  2014cited by this paper
• Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial.

  2014cited by this paper
• Does a Patient-Managed Insulin Intensification Strategy With Insulin Glargine and Insulin Glulisine Provide Similar Glycemic Control as a Physician-Managed Strategy? Results of the START (Self-Titration With Apidra to Reach Target) Study

  2014influential reference
• Clinical Inertia in People With Type 2 Diabetes

  2013cited by this paper
• American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.

  2013cited by this paper
• Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis

  2013cited by this paper
• Intensification of Basal Insulin Therapy with Step-Wise Addition of Insulin Aspart Boluses vs. Basal-Bolus Therapy: The FullSTEP™ Study

  2013cited by this paper
• Safety and Effectiveness of Insulin Aspart in Basal-Bolus Regimens Regardless of Age: A1chieve Study Results

  2013cited by this paper
• Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.

  2013cited by this paper
• Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

  2013cited by this paper
• Comparison of Safety and Efficacy of Insulin Glargine and Neutral Protamine Hagedorn Insulin in Older Adults with Type 2 Diabetes Mellitus: Results from a Pooled Analysis

  2012cited by this paper
• Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes

  2011cited by this paper
• A new classification approach for comparing two active treatments when there is no prior projection on which one is better

  2011cited by this paper
• Multidrug Treatment of Type 2 Diabetes

  2011cited by this paper
• Efficacy of Insulin Analogs in Achieving the Hemoglobin A1c Target of <7% in Type 2 Diabetes

  2011cited by this paper
• Treatment regimens with insulin analogues and haemoglobin A1c target of <7% in type 2 diabetes: a systematic review.

  2011cited by this paper
• Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs

  2010cited by this paper
• Diabetes Medications Related to an Increased Risk of Falls and Fall-Related Morbidity in the Elderly

  2010cited by this paper
• A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial).

  2009cited by this paper
• Three-year efficacy of complex insulin regimens in type 2 diabetes.

  2009cited by this paper
• Insulin therapy in type 2 diabetes is no longer a secondary care activity in the Netherlands.

  2009cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Why Don’t Diabetes Patients Achieve Recommended Risk Factor Targets? Poor Adherence versus Lack of Treatment Intensification

  2008cited by this paper
• Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials

  2008cited by this paper
• Initiate Insulin by Aggressive Titration and Education (INITIATE): A randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups

  2008cited by this paper
• Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort study.

  2007cited by this paper
• Initiate Insulin by Aggressive Titration and Education (INITIATE)

  2007cited by this paper
• Advancing Insulin Therapy in Type 2 Diabetes Previously Treated With Glargine Plus Oral Agents

  2007cited by this paper
• Systematically Initiating Insulin

  2006cited by this paper
• [Systematically Initiating Insulin: The Staged Diabetes Management Approach]

  2006cited by this paper
• Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study.

  2005cited by this paper
• Clinical inertia in response to inadequate glycemic control: do specialists differ from primary care physicians?

  2005cited by this paper
• Evaluating risk factors associated with severe hypoglycaemia in epidemiology studies—what method should we use?

  2004cited by this paper
• The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes.

  2004cited by this paper
• The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

  2003cited by this paper
• Glimepiride Combined with Morning Insulin Glargine, Bedtime Neutral Protamine Hagedorn Insulin, or Bedtime Insulin Glargine in Patients with Type 2 Diabetes

  2003cited by this paper
• Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

  2002cited by this paper
• Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

  2000cited by this paper
• A Simple Therapeutic Combination for Type 2 Diabetes

  2000cited by this paper
• Cancer: The Emerging Molecular Biology

  2000cited by this paper
• Who looks after people with diabetes: Primary or secondary care?

  2000cited by this paper
• Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

  1999cited by this paper
• Glycemic Control with Diet, Sulfonylurea, Metformin, or Insulin in Patients with Type 2 Diabetes Mellitus: Progressive Requirement for Multiple Therapies (UKPDS 49)

  1999cited by this paper
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

  1998cited by this paper
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

  1998cited by this paper
• World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects.

  1997cited by this paper
• Recommendations guiding physicians in biomedical research involving human subjects. World Medical Association Declaration of Helsinki.

  1994cited by this paper
• Evening Insulin Strategy

  1990cited by this paper

• Comparison of Insulin Titration Strategies for Glycemic Control in Type 2 Diabetes: A Systematic Review and Network Meta-analysis.

  2025cites this paper
• The Effective Use by Primary Care Clinicians of a Comprehensive Computerized Insulin Dose Adjustment Algorithm.

  2024cites this paper
• Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range

  2023cites this paper
• Transforming Evidence Generation for Drug Label Changes: A Case Study

  2022cites this paper
• Intensificación del tratamiento con insulina. Transición de pautas

  2022cites this paper
• Inpatient and Outpatient Technologies to Assist in the Management of Insulin Dosing

  2020cites this paper
• The burden of type 2 diabetes in Europe: current and future aspects of insulin treatment from patient and healthcare spending perspectives.

  2020cites this paper
• Biosynthetic Human Insulin and Insulin Analogs.

  2020cites this paper
• Dietary Intake and Type 2 Diabetes

  2019cites this paper
• Effect of Remote Glucose Monitoring Utilizing Computerized Insulin Dose Adjustment Algorithms: A Pilot Project

  2019cites this paper
• Insulin in Type 1 and Type 2 Diabetes—Should the Dose of Insulin Before a Meal be Based on Glycemia or Meal Content?

  2019cites this paper
• A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus

  2018influential citation
• Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION‐7 randomized study

  2018cites this paper
• Strategies for implementing effective mealtime insulin therapy in type 2 diabetes

  2018cites this paper
• Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets

  2018influential citation
• When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus

  2017cites this paper
• Efficacy of Exenatide Plus Pioglitazone Vs Basal/Bolus Insulin in T2DM Patients With Very High HbA1c

  2017cites this paper
• Adding fast‐acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes: A randomized, 18‐week, open‐label, phase 3 trial (onset 3)

  2017cites this paper
• Factors associated with reaching or not reaching target HbA1c after initiation of basal or premixed insulin in patients with type 2 diabetes.

  2017cites this paper
• Review of basal‐plus insulin regimen options for simpler insulin intensification in people with Type 2 diabetes mellitus

  2017cites this paper
• Titration of basal insulin or immediate addition of rapid acting insulin in patients not at target using basal insulin supported oral antidiabetic treatment - A prospective observational study in 2202 patients.

  2017cites this paper
• Basal insulin treatment intensification in patients with type 2 diabetes mellitus: A comprehensive systematic review of current options.

  2017cites this paper
• Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes

  2017cites this paper
• Simulation-Based Evaluation of Dose-Titration Algorithms for Rapid-Acting Insulin in Subjects with Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antihyperglycemic Medications

  2017influential citation
• Five Simple Steps to Optimize Bolus Insulin Therapy in Type 2 Diabetes

  2017influential citation
• A review of insulin lispro for the treatment of patients with type 2 diabetes mellitus

  2016cites this paper
• Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co‐formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trial

  2016cites this paper
• Principles of self-adjustment of insulin dose in people with diabetes type 2 and flexible insulin therapy.

  2016cites this paper
• Efficacy and safety of a premixed versus a basal-plus insulin regimen as intensification for type 2 diabetes by timing of the main meal

  2016cites this paper
• A Patient-Driven Approach to Manage Mealtime Insulin Titration

  2016cites this paper
• A review of insulin lispro for the treatment of patients with type 2 diabetes mellitus

  2016cites this paper
• Evaluation of a patient self-directed mealtime insulin titration algorithm: a US payer perspective

  2016cites this paper
• Insulin Management in Type 2 Diabetes

  2016cites this paper
• Insulin tactics in type 2 diabetes.

  2015cites this paper
• THE DAMPING PARAMETERS CYE (CURB YOUR ENTHUSIASM) AND DSP (DOWNSCALE PRE-EMPTIVELY) FOR BASAL INSULIN THERAPY.

  2015cites this paper
• Options for intensification of basal insulin in type 2 diabetes: Premeal insulin or short-acting GLP-1 receptor agonists?

  2015cites this paper
• Response to Comment on Edelman et al. AUTONOMY: The First Randomized Trial Comparing Two Patient-Driven Approaches to Initiate and Titrate Prandial Insulin Lispro in Type 2 Diabetes. Diabetes Care 2014;37:2132–2140

  2014influential citation
• Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial

  2014cites this paper
• Comment on Edelman et al. AUTONOMY: The First Randomized Trial Comparing Two Patient-Driven Approaches to Initiate and Titrate Prandial Insulin Lispro in Type 2 Diabetes. Diabetes Care 2014;37:2132–2140

  2014cites this paper
• Management of Type 2 Diabetes - Methods for Addition of Prandial to Basal Insulin.

  2014cites this paper